Clinical Trial Update: Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating myeloablative conditioning, prophylactic defibrotide, and haploidentical allogeneic stem cell transplantation for sickle cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Defibrotide (defibrotide)

Snippet

Sponsor: New York Medical College | Conditions: Sickle Cell Disease | Phase 2 | Status: RECRUITING